ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

Univ. Of Washington, Fox Chase, ICC Win CCRU, CCSP Awards

July 8, 1983